Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Predicting clinically actionable metagenomic next-generation sequencing in sepsis through dynamic inflammatory trajectories.

Created on 04 Nov 2026

Authors

Xiaocheng Ding, Peng Bao, Xiaopeng Huang, Rui Xu, Xinyi Tang, Yuzhi Wu, Xiaoli Cui, Yang Lu

Published in

Frontiers in microbiology. Volume 17. Pages 1949602. Epub Oct 20, 2026.

Abstract

Metagenomic next-generation sequencing (mNGS) improves pathogen detection in sepsis, but positive results do not always prompt antimicrobial modification. We investigated whether dynamic host-response trajectories during the mNGS peri-report interval could predict clinical actionability.
This retrospective single-center study included 109 adults with sepsis who underwent mNGS and conventional culture, and 72 patients with complete prespecified predictor data entered model development. Baseline and dynamic logistic models were assessed for discrimination, calibration, prediction error, and exploratory decision-curve performance. Final fixed models underwent 1,000-resample bootstrap optimism correction.
mNGS positivity was 94.8% in the actionable group and 84.3% in the non-actionable group, with broader descriptive pathogen detection than culture. In the complete-case cohort, the peri-report change in white blood cell count (dWBC) remained associated with actionability after adjustment for the included baseline variables (adjusted OR, 1.14; 95% CI, 1.02-1.28; P = 0.025). Apparent AUC increased from 0.744 to 0.816 after adding dWBC. Optimism-corrected AUCs were 0.697 and 0.768, and corrected Brier scores were 0.228 and 0.207. No baseline-WBC interaction was detected (P = 0.494).
A less pronounced decline or an increase in WBC from pre-mNGS sampling to post-report reassessment was associated with a greater likelihood of subsequent documented mNGS-related antimicrobial modification.

PMID:
42978829
Bibliographic data and abstract were imported from PubMed on 04 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement